Table 2. Distribution of participants on lipid-lowering therapy and proportion achieving therapeutic target according to the FH groups.
Therapeutic target 44 - 47) | *# Potential FH ( n =53) | Definite FH ( n =14) | # Probable FH ( n =39) | # Possible FH ( n =354) |
---|---|---|---|---|
On lipid-lowering therapy # | 30 (56.6%) | 10 (71.4%) | 20 (51.3%) | 114 (32.2%) |
LDL-c <3.4 mmol/L | 1 (3.3%) | 0 | 1 (5.0%) | 8 (7.0%) |
(% achieving therapeutic target) | ||||
LDL-c <3.0 mmol/L | 0 | 0 | 0 | 1 (0.9%) |
(% achieving therapeutic target) | ||||
LDL-c ≤ 2.6 mmol/L | 0 | 0 | 0 | 0 |
(% achieving therapeutic target) | ||||
LDL-c <1.8 mmol/L | 0 | 0 | 0 | 0 |
(% achieving therapeutic target) | ||||
LDL-c <1.4 mmol/L | 0 | 0 | 0 | 0 |
(% achieving therapeutic target) |
* Potential FH is a combination of Definite and Probable FH
# Subjects with no data were excluded